Supriya Lifescience Limited has informed the Exchange about Recording of Analysts/Institutional Investor Meet/Con. CallIn accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligati...

Date: August 16, 2022

To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543434 Scrip Symbol: SUPRIYA

Bandra Kurla Complex

Dear Sir (s),

Subject: Audio recording of Earnings Call

Ref: Intimation of earnings conference call vide letter dated August 6, 2022

In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company's Earnings Call held today (i.e., August 16, 2022) regarding discussion on operational and financial performance for the First Quarter of FY 2022-2023 (Q1) is available on the Company's website.

The recording can be accessed from the link given below: https://supriyalifescience.com/investor-relation/financial/earning-call-recordings/

You are requested to kindly take the same on record.

Thanking you,

Yours faithfully, For Supriya Lifescience Limited

Shweta Singh Company Secretary & Compliance Officer Membership No.: A44973

Corporate office

: 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com

Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com

GOVT. RECOGNISED EXPORT HOUSE